The meningococcus tamed?

Journal article

Serogroup B Neisseria meningitidis is a frequent cause of invasive meningococcal disease, yet there are no effective vaccines suitable for routine immunisation. Limited efficacy has been shown with meningococcal outer membrane vacccines in children 4 years and older. Here we review the status of current research and consider new approaches to development of meningococcal serogroup B vaccines.

Authors: Pollard, A; Moxon, E

• Publication status: Published
• Journal: Archives of disease in childhood
• Volume: 87
• Issue: 1
• Pages: 13-17
• Publication date: 2002-07-01
• DOI: 10.1136/adc.87.1.13
• EISSN: 1468-2044
• ISSN: 0003-9888
• Language: English
• Keywords: Humans; Meningitis, Meningococcal; Child; Bacterial Outer Membrane Proteins; Lipopolysaccharides; Clinical Trials, Phase II as Topic; Meningococcal Vaccines; Neisseria meningitidis; Exotoxins; Clinical Trials, Phase III as Topic